Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (281-290 of 337) with videos related to

Pageof 34
Sort By:
BMJ Open|October 14, 2016
Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinionRianne A Weersink, Margriet Bouma, David M Burger, et al.
Archives of Disease in Childhood|May 11, 2016
A new paediatric formulation of valaciclovir: development and bioequivalence assessmentDiane E T Bastiaans, Carli M Bartels-Wilmer, Angela P H Colbers, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2003
Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavirJeanne P Dieleman, Annemarie M C van Rossum, Bruno C H Stricker, et al.
British Journal of Clinical Pharmacology|August 12, 2017
In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovirDiane E T Bastiaans, Laura I Immohr, Gertrude G Zeinstra, et al.
Wellcome Open Research|July 31, 2023
Pharmacokinetics and pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a protocol for a Phase II randomised controlled trialPeter Olupot-Olupot, William Okiror, Hellen Mnjalla, et al.
Molecules (Basel, Switzerland)|January 14, 2012
The effect of β-carotene supplementation on the pharmacokinetics of nelfinavir and its active metabolite M8 in HIV-1-infected patientsNancy L Sheehan, Rolf P G van Heeswijk, Brian C Foster, et al.
Analytical and Bioanalytical Chemistry|July 16, 2010
Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spotsRoland J W Meesters, Jeroen J A van Kampen, Mariska L Reedijk, et al.
Antiviral Therapy|May 17, 2007
Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and ZambiaJane C Ellis, Rafaella F A L'homme, Fiona M Ewings, et al.
Clinical Pharmacokinetics|March 10, 2018
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant WomenStein Schalkwijk, Rob Ter Heine, Angela C Colbers, et al.
Pediatric Nephrology (Berlin, Germany)|October 31, 2018
The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patientsAnne M Schijvens, Fransje H S van Hesteren, Elisabeth A M Cornelissen, et al.
Pageof 34

Showing results (281-290 of 337) with videos related to

Sort By:
Pageof 34
BMJ Open|October 14, 2016
Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinionRianne A Weersink, Margriet Bouma, David M Burger, et al.
Archives of Disease in Childhood|May 11, 2016
A new paediatric formulation of valaciclovir: development and bioequivalence assessmentDiane E T Bastiaans, Carli M Bartels-Wilmer, Angela P H Colbers, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2003
Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavirJeanne P Dieleman, Annemarie M C van Rossum, Bruno C H Stricker, et al.
British Journal of Clinical Pharmacology|August 12, 2017
In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovirDiane E T Bastiaans, Laura I Immohr, Gertrude G Zeinstra, et al.
Wellcome Open Research|July 31, 2023
Pharmacokinetics and pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a protocol for a Phase II randomised controlled trialPeter Olupot-Olupot, William Okiror, Hellen Mnjalla, et al.
Molecules (Basel, Switzerland)|January 14, 2012
The effect of β-carotene supplementation on the pharmacokinetics of nelfinavir and its active metabolite M8 in HIV-1-infected patientsNancy L Sheehan, Rolf P G van Heeswijk, Brian C Foster, et al.
Analytical and Bioanalytical Chemistry|July 16, 2010
Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spotsRoland J W Meesters, Jeroen J A van Kampen, Mariska L Reedijk, et al.
Antiviral Therapy|May 17, 2007
Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and ZambiaJane C Ellis, Rafaella F A L'homme, Fiona M Ewings, et al.
Clinical Pharmacokinetics|March 10, 2018
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant WomenStein Schalkwijk, Rob Ter Heine, Angela C Colbers, et al.
Pediatric Nephrology (Berlin, Germany)|October 31, 2018
The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patientsAnne M Schijvens, Fransje H S van Hesteren, Elisabeth A M Cornelissen, et al.
Pageof 34